A double blind study of metoclopramide in the treatment of migraine attacks.

類似資料

• Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study
  著者:: Tfelt-Hansen, P., 等
  出版事項: (2006)
• Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
  著者:: Tokola, R A, 等
  出版事項: (1984)
• Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register
  著者:: Tfelt-Hansen, Peer Carsten
  出版事項: (2011)
• The 5-HT(1F) receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
  著者:: Tfelt-Hansen, Peer C., 等
  出版事項: (2012)
• Which is more effective for the treatment of Acute Migraine Attack: Dexketoprofen, Ibuprofen or Metoclopramide?
  著者:: Karacabey, Sinan, 等
  出版事項: (2018)